Maravai Lifesciences Holdings (MRVI) Gross Profit (2020 - 2026)

Maravai Lifesciences Holdings' Gross Profit history runs 7 years deep, the most recent figure standing at $33.7 million for Q1 2026.

• In Q1 2026, Gross Profit rose 336.26% year-over-year to $33.7 million; the TTM figure through Mar 2026 stood at $60.0 million (down 33.51% YoY), while the FY2025 annual figure was $34.0 million, down 68.62% from the prior year.
• Gross Profit was $33.7 million for Q1 2026 at Maravai Lifesciences Holdings, up from $12.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $205.2 million in Q2 2022 to a low of $5.7 million in Q3 2025.
• Historically, Gross Profit has averaged $60.6 million across 5 years, with a median of $30.8 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Gross Profit sank 87.51% in 2023, then soared 336.26% in 2026.
• A 5-year view of Gross Profit shows it stood at $151.5 million in 2022, then slumped by 74.23% to $39.0 million in 2023, then plunged by 50.32% to $19.4 million in 2024, then sank by 33.77% to $12.8 million in 2025, then surged by 162.43% to $33.7 million in 2026.
• The last three Gross Profit figures came in at $33.7 million (Q1 2026), $12.8 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.